Theranos authorized new shares that would value the laboratory startup at over $10 billion, a filing shows, three days before The Wall Street Journal detailed the company’s struggles with its blood-testing technology.

Topics:  the wall street journal   theranos   shares   

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Technology News